Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF)

Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF)

US Patent 6245330 · Granted Jun 12, 2001

Estimated economic value: $5,503,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diet controlled expression of a nucleic acid encoding a pro-apoptotic protein2025
CD28/OX40 bispecific antibodies2025
Adenovirus vaccine vectors2018
Use of jasmonate ester derivatives for treating benign hyperproliferative skin d2016
Recombinant adenoviruses encoding the specific iodine transporter (NIS)2014
Pharmaceutical compositions and utilization thereof particularly for the treatme2013
Pharmaceutical compositions and utilization thereof particularly for the treatme2013
Non-integrative and non-replicative lentivirus, preparation and uses thereof2012
RNAi mediated expression inhibition of a cholinergic protein2011
Methods of gene transfer to astrocytes with mokola virus pseudotyped lentivirus 2010
Neuronal gene transfer of adenovirus and herpes virus vectors2008
Defective recombinant adenoviruses expressing cytokines for antitumor treatment2007